These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22653025)

  • 1. [Clinical application of FRAX® in Japan].
    Hosoi T
    Clin Calcium; 2012 Jun; 22(6):857-63. PubMed ID: 22653025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the FRAX and Garvan fracture risk calculators in older women.
    Bolland MJ; Siu AT; Mason BH; Horne AM; Ames RW; Grey AB; Gamble GD; Reid IR
    J Bone Miner Res; 2011 Feb; 26(2):420-7. PubMed ID: 20721930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recommendations of FRAX in clinical assessment of osteoporosis indicated in European and US guidelines].
    Nakamura T
    Clin Calcium; 2009 Dec; 19(12):1723-8. PubMed ID: 19949262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fracture burden in relation to low bone mineral density and FRAX(®) probability.
    Leslie WD; Morin S
    J Clin Densitom; 2011; 14(3):279-85. PubMed ID: 21723761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Utility of Fracture Risk Assessment Tool (FRAX)].
    Fujiwara S
    Nihon Rinsho; 2011 Jul; 69(7):1239-42. PubMed ID: 21774364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic purpose and treatment guideline of osteoporosis].
    Ogawa S; Ouchi Y
    Clin Calcium; 2012 Jun; 22(6):885-9. PubMed ID: 22653029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probability of fractures predicted by FRAX® and observed incidence in the Spanish ECOSAP Study cohort.
    González-Macías J; Marin F; Vila J; Díez-Pérez A
    Bone; 2012 Jan; 50(1):373-7. PubMed ID: 22129640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fracture Risk Assessment Tool (FRAX®) Results Calculated With and Without Bone Mineral Density Values for the Evaluation of Fracture Risk in Postmenopausal Women With Osteopenia.
    Imerci A; Yalın Kılınç C; Aydogan NH; Karalezli MN; Savran A
    J Clin Densitom; 2018; 21(4):464-471. PubMed ID: 28781230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology of bone and joint disease - the present and future - . Epidemiology of osteoporosis and osteoporotic fracture in Japan].
    Iki M
    Clin Calcium; 2014 May; 24(5):657-64. PubMed ID: 24769675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there an interaction between socioeconomic status and FRAX 10-year fracture probability determined with and without bone density measures? Data from the Geelong Osteoporosis Study of female cohort.
    Brennan SL; Quirk SE; Hosking SM; Kotowicz MA; Holloway KL; Moloney DJ; Dobbins AG; Pasco JA
    Calcif Tissue Int; 2015 Feb; 96(2):138-44. PubMed ID: 25578145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of osteoporotic fractures in the group of woman over 50 years of age--comparison of tools FRAX BMD versus FRAX BMI].
    Strugala C; Sobala W; Szubert Z; Hanke W
    Med Pr; 2013; 64(3):327-33. PubMed ID: 24261246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of FRAX and future issues in women's health].
    Hashimoto K; Ishitani K; Ohta H
    Clin Calcium; 2009 Dec; 19(12):1742-8. PubMed ID: 19949265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical decision and patient education of pharmacotherapy for osteoporosis].
    Hosoi T
    Nihon Rinsho; 2009 May; 67(5):909-13. PubMed ID: 19432108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development and application of fracture risk assessments].
    Nakamura T
    Clin Calcium; 2012 Jun; 22(6):819-24. PubMed ID: 22653019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the fracture risk assessment tool (FRAX(®)) and determination of suitable cut-off values during primary screening in specific health check-ups in Japan.
    Nakatoh S; Takemaru Y
    J Bone Miner Metab; 2013 Nov; 31(6):674-80. PubMed ID: 23543192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fracture Risk Assessment Tool May Not Indicate Bone Fragility in Women With Type 2 Diabetes.
    Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
    Am J Med Sci; 2020 Nov; 360(5):552-559. PubMed ID: 32376002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The fracture risk assessment tool (FRAXTM), where are we in Tunisia?].
    Zrour-Hassen S; Jguirim M; Guezguez M; Mnif H; Younes M; Bejia I; Touzi M; Abid A; Essabah H; Bergaoui N
    Tunis Med; 2011 Feb; 89(2):136-41. PubMed ID: 21308620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New horizons in fracture risk assessment.
    Aspray TJ
    Age Ageing; 2013 Sep; 42(5):548-54. PubMed ID: 23892830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Utility and problems of FRAX in clinical use].
    Nakatoh S
    Clin Calcium; 2009 Dec; 19(12):1756-67. PubMed ID: 19949267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.